Brief: Ondine Biomedical Proposed A C.£11 Mln Fundraise
Aug 27 (Reuters) - Ondine Biomedical Inc OBI.L: ONDINE BIOMEDICAL - PROPOSED C.£11M FUNDRAISE ONDINE BIOMEDICAL INC - FUNDRAISING EXPECTED TO EXTEND CASH RUNWAY TO END OF H1 2026 ONDINE BIOMEDICAL INC - FUNDRAISING PROCEEDS ALLOCATED TO CLINICAL TRIALS AND GROWTH Source text: ID:nRSa9296Wa Further company coverage: OBI.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ondine Biomedical
See all newsBrief: Ondine Lantern Phase 3 Database Lock Expected Within A Week; Top-Line Results In 1-2 Weeks
Ondine Biomedical - Leeds Drops SSIs by 78.5% in Complex Brain Surgery
Brief: Ondine Biomedical Expects 2026 To Be A Defining Year For Company
Ondine Biomedical - Notice of AGM
Ondine Biomedical - 2025 Full Year Results and Annual Report